MSH2 p.Ala640=
c.1920T>C · rs1667244960 · VCV1692288
Benign/Likely benign
Multiple submitters
Classification
Benign/Likely benign
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 3 submitters
gnomAD v4.1
Rare
very rare (popmax 0.00133%, afr)
Conditions
2
hereditary neoplastic syndrome
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -0.14 | GERP -1.7, phastCons 0.76 |
| Overall | ||
| CADD | 7.535 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
gnomAD v4.1 · exomes + genomes
Grpmax group
0.00133%
African / African-American · 1/75,030 alleles
Overall
6.2e-05%
1/1,614,148 alleles · very rare
exomes 1/1,461,868 · genomes 0/152,280 · joint denominator
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- MSH2
- Protein
- p.Ala640=
- Coding
- c.1920T>C
- MANE Select
- NM_000251
- dbSNP
- rs1667244960
- Type
- single nucleotide variant
- Location
- chr2:47475185 (GRCh38)
- Gene constraint
- LOEUF 0.672 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
- Structure
- AlphaFold pLDDT 85.60 · 30 PDB
- Residue 640
- the 'interaction with exo1' region
Similar variants
- MSH2 p.Ala640Ser Benign/Likely benign ★★ same residue
- MSH2 p.Ala640Gly Uncertain significance ★ ⚠ same residue
- MSH2 p.Ala640Thr Uncertain significance ★ same residue
- MSH2 c.1076+1G>A Pathogenic ★★★ same condition
- MSH2 c.1076+1G>T Likely pathogenic ★★★ same condition
- MSH2 c.1077-1G>C Likely pathogenic ★★★ same condition
- MSH2 c.1077-1G>T Likely pathogenic ★★★ same condition
- MSH2 c.1077-2A>C Pathogenic ★★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/msh2-p-ala640 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown